VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281 | -99.2% | 30 | -97.9% | 0.00% | – |
| Q2 2023 | $34,882 | +145241.7% | 1,422 | +35.4% | 0.00% | – |
| Q1 2023 | $24 | -11.1% | 1,050 | 0.0% | 0.00% | – |
| Q4 2022 | $27 | -99.9% | 1,050 | 0.0% | 0.00% | – |
| Q3 2022 | $23,000 | -8.0% | 1,050 | +5.0% | 0.00% | – |
| Q2 2022 | $25,000 | +127.3% | 1,000 | +127.3% | 0.00% | – |
| Q1 2022 | $11,000 | -77.6% | 440 | -69.2% | 0.00% | – |
| Q4 2021 | $49,000 | +122.7% | 1,430 | +186.0% | 0.00% | – |
| Q3 2021 | $22,000 | -8.3% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | -7.7% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $26,000 | -16.1% | 500 | -56.9% | 0.00% | – |
| Q4 2020 | $31,000 | -64.8% | 1,160 | -54.7% | 0.00% | -100.0% |
| Q3 2020 | $88,000 | +363.2% | 2,563 | +457.2% | 0.00% | – |
| Q2 2020 | $19,000 | +533.3% | 460 | +360.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |